U.S. Markets close in 25 mins.

Supernus Pharmaceuticals, Inc. (SUPN)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
34.50-0.05 (-0.14%)
As of 3:34PM EDT. Market open.
People also watch
SCMPPCRXOMERIRWDHZNP
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue215,003147,46592,678
Cost of Revenue11,9868,4235,758
Gross Profit203,017139,04286,920
Operating Expenses
Research Development42,79129,13519,586
Selling General and Administrative106,01089,06372,612
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss54,21620,844-5,278
Income from Continuing Operations
Total Other Income/Expenses Net1,244-1,464604
Earnings Before Interest and Taxes55,46019,380-4,674
Interest Expense5,0914,7705,621
Income Before Tax50,36914,610-10,295
Income Tax Expense-40,852666630
Minority Interest---
Net Income From Continuing Ops90,55011,606-13,517
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income91,22113,944-10,925
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares91,22113,944-10,925